Related Experiment Video
Updated: Jan 9, 2026

06:19
Constructing and Visualizing Models using Mime-based Machine-learning Framework
Published on: July 22, 2025
2.2K
MoMA: a mixture-of-multimodal-agents architecture for enhancing clinical prediction modelling.
Jifan Gao1, Mahmudur Rahman1, John Caskey1
1University of Wisconsin-Madison, Madison, WI, USA.
NPJ Digital Medicine
|December 9, 2025
Summary
A new Mixture-of-Multimodal-Agents (MoMA) architecture uses multiple large language model (LLM) agents to integrate diverse electronic health record (EHR) data for improved clinical predictions.
Area of Science:
- Artificial Intelligence in Medicine
- Clinical Informatics
- Biomedical Data Science
Background:
- Multimodal electronic health record (EHR) data offer comprehensive patient insights but integrating them for clinical prediction is data-intensive and challenging.
- Existing methods struggle with the heterogeneity and volume of multimodal EHR data, limiting predictive accuracy.
Purpose of the Study:
- To introduce a novel architecture, Mixture-of-Multimodal-Agents (MoMA), for effective clinical prediction using multimodal EHR data.
- To leverage multiple large language model (LLM) agents to overcome data integration challenges in multimodal EHR analysis.
Main Methods:
- MoMA utilizes specialized LLM agents to convert non-textual data (images, labs) into structured textual summaries.
- An aggregator LLM agent combines these summaries with clinical notes into a unified multimodal summary.
- A predictor LLM agent generates clinical predictions based on the unified summary.
Main Results:
- MoMA demonstrated superior performance compared to existing methods across three distinct clinical prediction tasks.
- The architecture was evaluated using various combinations of data modalities and prediction settings on private datasets.
- MoMA achieved enhanced accuracy and flexibility in multimodal EHR data analysis.
Conclusions:
- The MoMA architecture effectively integrates diverse multimodal EHR data for clinical prediction.
- MoMA offers a flexible and accurate approach to leveraging LLM agents for complex healthcare data challenges.
- This novel method shows significant potential for advancing clinical prediction modeling using rich EHR information.
Related Concept Videos
Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Multicompartment Models: Overview
474
Multicompartment models are mathematical constructs that depict how drugs are distributed and eliminated within the body. They segment the body into several compartments, symbolizing various physiological or anatomical areas connected through drug transfer processes such as absorption, metabolism, distribution, and elimination.
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
474
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
223
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
223
Pharmacokinetic Models: Comparison and Selection Criterion
309
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
309
Combined Effects of Drugs: Synergism
6.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.7K